SMID Biotech Stocks Update to our Trading Model with BULL Market Intact
Trading Model for SMID Biotech Stocks is Still Bullish Core position for a biotech portfolio remains large cap biopharmaceuticals including funds such as FBIOX up 2.1% YTD. We have developed parameters to track "risk on or risk off" trading windows with the XBI up 5.77%. Objective is to select...
Healthcare Sector Watch after a Bad Week, but Biotech is still Tradeable…Update-4..biotech rally!
Update-4 ..4/2/26..uh oh back onto tariff talk again ! NOT good for the market. Tariffs aren't good for business in general. BUT with our WAR in Iran ,and AI they create more chaos. Update-3 4/1/26...Another Green Day for biotech. If you are not in yet a good trade is to buy the IBB at $170,...
Healthcare Sector Review : Q1 2026 Cutbacks in Government Spending are Taking its Toll…Update-4
Update-4 The market continued in its sell-off to the Fifth Week as the WAR in Iran pervades all thinking.If crude is up then stocks will be down. The latest timeline for the War with Iran for any sort of clarity of outcome is around six weeks.In the meantime that period can generate a lot of...
Follow Sector Rotation This Week in Midst of War with Iran…Update-5…MedTech
What is your portfolio allocation by sector?
Large Cap Biopharmaceuticals: Still a Core Position for Your Portfolio…Update-2
Update-2 3/6/26... After the close learned that UBS upgraded biopharma stocks. Will review the sector over the weekend. XBI turned green and flat not down at the close. The IBB found buyers at $167. XNCR was up 1.35 at $11. Update-1 3/5/26 8:45A...Biotech stocks weak Royalty issues with XENCOR!...